This growth opportunity analytics identifies the developments shaping the global pharmaceutical landscape. The growth of the global pharmaceutical sector will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics.
• What are the growth opportunities emerging from this space for stakeholders and key players to leverage?
• How much is the sector expected to grow in 2023?
• Will pharmaceutical companies continue to shift towards regional suppliers rather than global suppliers to ensure geographic proximity and a smoother, more reliable supply chain?
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
